Criteria for screening diabetes mellitus using serum fructosamine level and fasting plasma glucose level. The Japanese Society of Multiphasic Health Testing and Services (JMHT), Fructosamine Working Committee.
A screening method using serum fructosamine level and the fasting plasma glucose level was used for screening patients with diabetes mellitus. The criteria for positive tests recommended by the Japanese Society of Multiphasic Health Testing and Services were evaluated. It was found that levels for the serum fructosamine of 290 mumol/l or higher (or, for the fasting plasma glucose of 110 mg/dl or higher) agreed with the standard oral glucose tolerance test in identifying patients with diabetes mellitus in 96.7% of cases, and the serum fructosamine test was simpler and less expensive.
Kasezawa
N
N
Departmnt of Clinical Biology, Shizuoka Medical Center, Japan.
Kiyose
H
H
Ito
K
K
Iwatsuka
T
T
Kawai
H
H
Goto
Y
Y
Kondo
K
K
Sasamori
N
N
Suzuki
K
K
Suzuki
T
T
D000293:Adolescent; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism*; D003431:Cross-Cultural Comparison; D005260:Female; D019270:Fructosamine; D005951:Glucose Tolerance Test; D006595:Hexosamines / Q000097:blood*; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D009098:Multiphasic Screening; D011237:Predictive Value of Tests; D011785:Quality Assurance, Health Care
D001786:Blood Glucose; D006595:Hexosamines; D019270:Fructosamine